Form 4: LifeStance Health Group Director Acquires Restricted Stock Units
SEC Form 4
Director Teresa DeLuca acquired 36,363 restricted stock units in LifeStance Health Group, Inc.
Summary
- On July 21, 2024, Teresa DeLuca, a director of LifeStance Health Group, Inc., acquired 36,363 restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- DeLuca also indirectly owns shares through Yawaog Enterprises Corp., where she is the controlling shareholder.
- DeLuca disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Sentiment
Score: 5
Explanation: This is a neutral filing reflecting a standard transaction. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to ensure transparency of trading by corporate insiders.
Stakeholder Impact
- The acquisition of RSUs by a director could be perceived positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 07/21/2024 | Date of transaction: Teresa DeLuca acquired 36,363 restricted stock units. |
| 08/27/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.